Top Warning Letter Trends of 2019
The FDA’s warning letters for 2019 once again targeted many familiar GMP failures, such as quality units that either lacked or failed to follow written procedures.
Source: Drug Industry Daily
The FDA’s warning letters for 2019 once again targeted many familiar GMP failures, such as quality units that either lacked or failed to follow written procedures.
Source: Drug Industry Daily